Ratings Manulife Financial Corporation Hong Kong S.E.

Equities

945 CA56501R1064

Delayed Hong Kong S.E. Other stock markets 11:27:21 2024-04-25 pm EDT			5-day change	1st Jan Change
183.1 ^HKD	+0.33%		+3.10%	+6.83%

Apr. 17	TSX Closer: Market Manages To Finish Up 13 Points After MIdday Plunge	MT
Apr. 17	National Bank on Federal Budget's Impact on Banks -- "No Big Surprises, Just More Clarity"	MT

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

Thanks to a sound financial situation, the firm has significant leeway for investment.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
The company has a low valuation given the cash flows generated by its activity.
The company is one of the best yield companies with high dividend expectations.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
Over the past four months, analysts' average price target has been revised upwards significantly.
Over the past twelve months, analysts' opinions have been strongly revised upwards.
Historically, the company has been releasing figures that are above expectations.

Ratings chart - Surperformance

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
MANULIFE FINANCIAL CORPORATION	+6.83%	41.99B	-
AXA	+14.62%	79.66B	B-
METLIFE, INC.	+8.73%	51.99B	B+
AFLAC INCORPORATED	+1.49%	48.18B	B
PRUDENTIAL FINANCIAL, INC.	+7.20%	39.96B	B+
GENERALI	+19.13%	37.85B	B
GREAT-WEST LIFECO INC.	-8.37%	27.37B	B-
PRUDENTIAL PLC	-19.52%	24.45B	A-
CATHAY FINANCIAL HOLDING CO., LTD.	+6.12%	21.84B	A
DAI-ICHI LIFE HOLDINGS, INC.	+21.02%	21.14B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes